Tyrosine News and Research

RSS
Chronic myelogenous leukemia patient survey shows that side effects are a serious issue

Chronic myelogenous leukemia patient survey shows that side effects are a serious issue

New chemotherapy pill shows promise for stubborn lymphomas

New chemotherapy pill shows promise for stubborn lymphomas

Genaera starts trial of Trodusquemine in overweight and obese type 2 diabetes

Genaera starts trial of Trodusquemine in overweight and obese type 2 diabetes

Gefitinib just as effective as chemotherapy for lung cancer

Gefitinib just as effective as chemotherapy for lung cancer

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Kinase inhibitors may offer new therapeutic approach for treatment of type 1 diabetes

Kinase inhibitors may offer new therapeutic approach for treatment of type 1 diabetes

Two common cancer drugs prevent, reverse type 1 diabetes

Two common cancer drugs prevent, reverse type 1 diabetes

Alteration of a gene causes neuroblastoma

Alteration of a gene causes neuroblastoma

Scientists sequence genome of a cancer patient

Scientists sequence genome of a cancer patient

YM Biosciences reports on early trials of nimotuzumab in brain metastases and high-grade glioma

YM Biosciences reports on early trials of nimotuzumab in brain metastases and high-grade glioma

Gene study sheds new light on lung cancer

Gene study sheds new light on lung cancer

Getting to grips with the complexity of disease proteins

Getting to grips with the complexity of disease proteins

Significant benefits in non-small-cell lung cancer from customizing erlotinib treatment

Significant benefits in non-small-cell lung cancer from customizing erlotinib treatment

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma

VioQuest Pharmaceuticals issued new U.S. patent for Lenocta

VioQuest Pharmaceuticals issued new U.S. patent for Lenocta

Australian researchers reveal how cancers become more aggressive

Australian researchers reveal how cancers become more aggressive

Cancer survival secrets discovered by Australian researchers

Cancer survival secrets discovered by Australian researchers

Researcher develops method for early detection of leukemia relapse

Researcher develops method for early detection of leukemia relapse

Circulating tumor cells can reveal genetic signature of dangerous lung cancers

Circulating tumor cells can reveal genetic signature of dangerous lung cancers

Funding boost in fight against leukaemia

Funding boost in fight against leukaemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.